Laser indirect ophthalmoscopy offer advantages like wider field of view, better image resolution, less irritation to the ocular surface, and ease in ophthalmic examination because the ophthalmoscope is mounted on the forehead of the physician/ophthalmologist. Indirect ophthalmoscopes available today facilitate improvements in eye examination results, and care.
Manufacturers like Welch Allyn, Heine Optotechnik GmbH & Co. KG, Iridex Corporation, Keeler Limited, et al. offer technologically advanced laser indirect ophthalmoscopes.
As an example, Smart LIO offered by Lumenis may be a multiwavelength system within the market, and is compatible with multiple Lumenis photo coagulators. Smart LIO supports three wavelengths like 532 nm (green), 577 nm (yellow), and 659 nm (red).
Other technological advancements include adjustable interpupillary distance, adjustable mirrors, portable power packs, dust sealed optics, et al. .
These factors are expected to drive the worldwide Laser Indirect Ophthalmoscope Market growth over the forecast period.
Rising prevalence of certain ophthalmic diseases like peripheral neovascularization, lattice degeneration, and diabetic retinopathy is driving growth of the market.
As an example, consistent with the Royal National Institute of Blind People (RNIB), over 5.7 million people are affected by sight-threatening eye conditions within the U.K, in 2014.
Moreover, 2 million people were affected by sight loss in 2016, which is predicted to extend to over 2.7 million people by 2030.
Buy Research Report: COVID-19 Inhibits Demand for Processed Meat amid Bottlenecks in Supply and Production
Buy Research Report: Oligonucleotide Synthesis Market on a Positive Growth Trajectory, Supported by Developments in Synthetic Chemistry, Projects
Buy Research Report: Global Advance Wound Care Market to Reach Nearly US$ 15 Billion by 2030
Buy Research Report: Sales of Isobutylene to Ride on Gas Permeability Quotient; Uptake by End-use Industries Limited by COVID-19 Outbreak
Buy Research Report: Wild Pollock Gains Traction as Better Substitute to Cod; Market to Record Relatively Slow Growth Rate Through 2030
The global Laser Indirect Ophthalmoscope Market size was valued at $89.5 million in 2017. Laser Indirect Ophthalmoscope Market to Witness Strong CAGR of 4.2% over the Forecast Period (2018–2026)
Increasing healthcare expenditures for the treatment of sight loss, blindness, and sight-threatening conditions are expected to propel demand for basic eye care and examination, thereby propelling demand for necessary equipment like laser indirect ophthalmoscopes over the forecast period.
Consistent with the RNIB- Eye Health 2016 report, in the U.K., during 2016, sight loss, blindness, and sight-threatening conditions accounted for $2.03 million, $0.27 million, and $5.7 million healthcare expenditures, respectively.
Product recalls are expected to restrain the worldwide laser indirect ophthalmoscope market growth over the forecast period.
As an example, in February 2018, Iridex Corporation voluntarily recalled TruFocus LIO Premiere Laser Indirect Ophthalmoscope, as three adverse events occurred during procedures during which the TruFocus LIO Premiere was used.
Some main players operating within the global Laser Indirect Ophthalmoscope Market include Ellex Medical Lasers Ltd, Iridex Corporation, Alcon, Carl Zeiss Meditec AG, Lumenis Ltd., Topcon Medical Laser System, Nidek Co. Inc., Ziemer Ophthalmic Systems AG, Heine Optotechnik GmbH, and Keeler Ltd.